Back to search
FDAFDA · Food and drugs·Recall number D-1278-2014

Lidocaine HCl Injection, USP, 2%, 20 mg per mL, packaged in 5-mL single-dose vials, 10 vials per box, Rx Only, Hospira, Inc., Lake Forest, IL. 60045, NDC 0409-2066-05.

Published May 7, 2014 · Recall initiated: December 23, 2013

Summary

FDA records drug Class I recall D-1278-2014, published May 7, 2014 and initiated December 23, 2013. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 68,350 vials; Lot: Lot 32135DD; Exp 08/15. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter- Confimed customer complaint of particulates embedded in glass container and in contact with product solution.

What to do

Voluntary: Firm initiated · Press Release

Get an email if LIDOCAINE HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LIDOCAINE HYDROCHLORIDE
Manufacturer
Hospira Inc.
Distributor
Nationwide
Lot
Lot 32135DD; Exp 08/15
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lidocaine HCl Injection, USP, 2%, 20 mg per mL, packaged in 5-mL single-dose vials, 10 vials per box, Rx Only, Hospira, Inc., Lake Forest, IL. 60045, NDC 0409-2066-05. recalled?

Yes. FDA published recall D-1278-2014 on May 7, 2014. Reported hazard: Presence of Particulate Matter- Confimed customer complaint of particulates embedded in glass container and in contact with product solution.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LIDOCAINE HYDROCHLORIDE.